Varex Imaging (FRA:VI4) Loans Receivable: €0.0 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:VI4 Varex Imaging Corp FRA:VI4
70 GF Score
Price €10.20
GF Value €11.41
! 3 Warning Signs
View Full Analysis

What is Varex Imaging Loans Receivable?

Varex Imaging FRA:VI4 +5.15% 70 Loans Receivable is €0.0 Mil as of Mar. 2026. GuruFocus rates FRA:VI4 with a GF Score™ of 70/100 and a GF Value™ of €11.41. The stock has 3 warning signs investors should review.

Varex Imaging's Loans Receivable for the quarter that ended in Mar. 2026 was €0.0 Mil.

Varex Imaging Loans Receivable Historical Data

* Premium members only.

The historical data trend for Varex Imaging's Loans Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Varex Imaging Loans Receivable Chart

Varex Imaging Annual Data
Trend Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24 Sep25
Loans Receivable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Varex Imaging Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Loans Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
FRA:VI4
70GF Score
Varex Imaging Corp FRA:VI4
Loans Receivable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Varex Imaging Loans Receivable Calculation

Loans Receivable are the funds that a company has lent but have not yet been repaid.

Frequently Asked Questions Learn more about Loans Receivable →
What does a Loans Receivable of €0.0 Mil mean?
Varex Imaging (FRA:VI4) has a Loans Receivable of €0.0 Mil as of Mar. 2026. Loans Receivable are the funds that a company has lent but have not yet been repaid. View historical data on Varex Imaging and its competitors.
Is Varex Imaging's Loans Receivable too high?
Varex Imaging's current Loans Receivable is €0.0 Mil. Overall, Varex Imaging has a GF Score™ of 70/100, reflecting its overall financial health beyond just this single metric.
How does Varex Imaging's Loans Receivable compare to OFIX and VMD?
Varex Imaging's Loans Receivable of €0.0 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Loans Receivable for a Medical Devices & Instruments company?
A good Loans Receivable depends on the Medical Devices & Instruments industry context. However, Loans Receivable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Loans Receivable mean?
A high Loans Receivable can signal that a stock is expensive relative to its fundamentals. Loans Receivable are the funds that a company has lent but have not yet been repaid. View historical data on Varex Imaging and its competitors. Varex Imaging's current Loans Receivable is €0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Varex Imaging stock overvalued right now?
Varex Imaging (FRA:VI4) has a current Loans Receivable of €0.0 Mil. The stock's GF Value™ is €11.41, compared to a current price of €10.20 — trading 10.6% below its estimated fair value. The current Loans Receivable is €0.0 Mil. Varex Imaging's overall GF Score™ is 70/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Loans Receivable calculated?
Loans Receivable is calculated from a company's financial statements. For Varex Imaging (FRA:VI4), the current Loans Receivable is €0.0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Varex Imaging (FRA:VI4) Overvalued in 2026?

Based on GuruFocus' analysis, Varex Imaging stock appears to be undervalued. The current stock price of €10.20 is trading 10.6% below its estimated GF Value™ of €11.41.

Key valuation signals for FRA:VI4:

  • Loans Receivable: €0.0 Mil
  • GF Value™: €11.41 vs. price of €10.20 (10.6% below fair value)
  • GF Score™: 70/100 with 3 warning signs

No single metric tells the full story. See the FRA:VI4 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Varex Imaging Business Description

Other Exchanges VREX:USA
Address 1678 S. Pioneer Road, Salt Lake City, UT, USA, 84104
Varex Imaging Corp Designs, manufactures, sells, and services X-ray imaging components, including X-ray tubes, detectors, ionization chambers, high-voltage connectors, software, collimators, generators, exposure control devices, and heat exchangers.. The company operates through two segments: Medical, the key revenue driver, providing X-ray imaging components and accessories for healthcare applications, and Industrial, which provides Linatron X-ray accelerators, X-ray tubes, flat panel detectors, high-voltage connectors, and coolers for non-medical use. Geographically, it generates the majority of its revenue from Europe, the Middle East, and Africa (EMEA), with the rest coming from the Americas and Asia Pacific.
70GF Score

Get the complete analysis for FRA:VI4

Loans Receivable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€10.20
Price
€11.41
GF Value